SAXAGLIPTIN ADVISORY COMMITTEE MEETING

First Page		Document Content
Endocrinology Anatomy Liraglutide Papillary thyroid cancer Thyroid neoplasm Glucagon-like peptide-1 analog Medullary thyroid cancer Thyroid Cardiovascular disease Medicine Thyroid cancer Anti-diabetic drugs		SAXAGLIPTIN ADVISORY COMMITTEE MEETING Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 69,79 KB Share Document on Facebook

	EMDAC Background document Victoza (liraglutide) - LEADER FDA Briefing Document Endocrinologic and Metabolic Drugs Advisory Committee Meeting (EMDAC) DocID: 1ts1R - View Document
	Victoza (liraglutide [rDNA origin] injection DocID: 1nE7h - View Document
	Access to medicines - time for a progressive model Richard Bergström, EFPIA Director General 1 DocID: 1aTpx - View Document
	PDF Document DocID: 16ope - View Document
	12933_2015_206_Article 1..11 DocID: 15UUB - View Document